1 |
Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007 Nov;92(11):4241-7.
DOI
|
2 |
Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male. 2002 Jun;5(2):74-86.
DOI
|
3 |
Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl. 2006 Mar-Apr;27(2):135-7.
DOI
|
4 |
Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol. 2005 Jul;48(1):1-4.
DOI
|
5 |
Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl. 2005 Jun;28(3):125-7.
DOI
|
6 |
Lunenfeld B, Saad F, Hoesl CE. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Aging Male. 2005 Jun;8(2):59-74.
DOI
|
7 |
Werner AA. The male climacteric. J Am Med Assoc. 1946 Sep 28;132:188-94.
DOI
|
8 |
Min KS, Kang DI. Testosterone replacement therapy and monitoring for the male patients with testosterone deficiency syndrome. J Korean Med Assoc. 2011 Feb;54(2): 197-20.
DOI
|
9 |
Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005 Nov;60(11):1451-7.
DOI
|
10 |
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59.
DOI
|
11 |
Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male. 2009 Mar;12(1):5-12.
DOI
|
12 |
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59.
DOI
|
13 |
Lee KW. Huangjenaegyeongsomun, Seoul: Yeogang press; 2001. p. 31-8.
|
14 |
Park SY. The Relaxation Effects of Alpiniae Oxyphyllae Fructus on Isolated Corpus Cavernosum Smooth Muscle. Kor J Herbol. 2015;30(4):61-9.
|
15 |
Park SY. Relaxation Effects of Eucomiae Cortex in Isolated Rabbit Corpus Cavernosum Smooth Muscle. J Physiol & Pathol Korean Med. 2015;29(6):485-91.
DOI
|
16 |
Wang YS. Pharmacological applications of chinese medicine. Beijing: People's medical publishing house; 1983. p. 485-6.
|
17 |
Whang KT, Han JH, Kang SY. Effect of Batryticatus bombycis on the cerebral hemodynamics of rats. KOMP 1999;7(2):121-30.
|
18 |
Kim JJ. Andropause. KU today. 2003;autumn:32-3.
|
19 |
Shores MM, Matsumoto AM. Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):209-16.
DOI
|
20 |
Diamond J. Male menopause. Illinois: Sourcebooks; 1997.
|
21 |
Juul A, Skakkebaek NE. Androgens and the ageing male. Hum Reprod Update. 2002 Sep-Oct;8(5):423-33.
DOI
|
22 |
Kabir MR, Al-Amin MA, Siddique MA. Andropause: The Male Climacterium. TAJ 2008; 21(1): 87-92.
DOI
|
23 |
Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991 Nov;73(5):1016-25.
DOI
|
24 |
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001 Feb;86(2):724-31.
DOI
|
25 |
Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003 Jan;51(1):101-15.
DOI
|
26 |
Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med. 2004 Jan 29;350(5):482-92.
DOI
|
27 |
Muller M, van der Schouw YT, Thijssen JH, Grobbee DE. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab. 2003 Nov;88(11):5076-86.
DOI
|
28 |
Lee KS, Lee EK, Kim SY, Kim TH, Kim HP. Effect of mixed extract of Fenugreek seeds and Lespedeza cuneata on testosterone deficiency syndrome. Korean J Food Sci Technol. 2015;47(4):492-8.
DOI
|
29 |
Lee HS, Baek YS, Kim YS, Kim HP. Effects of Fermented dandelion(Taraxacum coreanum) extract on male climacteric syndrome. J Life Science. 2016;26(9):1063-73.
DOI
|
30 |
Kim TM, Jung HK, Jang JH, Sim MO, Lee MJ, Cho JH, et al. Effect of Corni Fructus on testosterone deficiency syndrome in In vitro and In vivo. Kor J Pharmacogn. 2016;47(3):264-72.
|
31 |
Shin MK. Clinical Herbology. 2nd ed. Seoul: Younglim press; 2002. p. 224-5.
|
32 |
Heo J. Donguibogam. Seoul: Namsandang; 1966. p. 741.
|
33 |
Ho SR. Local medicine of Chinese. Heilongjiang: Heilongjiang science and technology press; 1989. p. 270-3.
|
34 |
Lee SJ. Bonchogangmok. 2nd ed. Beijing: People's medical publishing house; 1982. p. 1986-7.
|
35 |
Shin MK. Clinical traditional herbology. 1st ed. Seoul: Younglim press; 1992. p. 663-4.
|
36 |
Kim CM, Shin MK, Lee KS, Ahn DK. The encyclopedia of oriental herbal medicine. Seoul: Jungdam books; 1998. p. 2015-9.
|
37 |
Lee JG, Kim EH, Lee JH. Effect of Gentianae Radix on Neurogenesis and Apoptosis in Hippocampus of Ethanol-induced Newborn Rats. J orient Neuropsychatr. 2010;21(2):29-44.
|
38 |
Lorenzetti V, Allen NB, Fornito A, Yucel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 2009;117(1-2):1-17.
DOI
|
39 |
McKinnon MC, Yucel K, Nazarov A, MacQueen GM. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci. 2009;34(1):41-54.
|
40 |
Eo J, Lim H. Effects of Bisphenol A on Gene Expression and Apoptosis of Leydig Cells in the Mouse Testis. Korean J Reprod Med. 2008 Sep;35(3):181-91.
|
41 |
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
DOI
|
42 |
Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006 Mar 10;160(1):1-40.
DOI
|
43 |
Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-66.
DOI
|
44 |
Bloom FE. Neuropeptides. Sci Am. 1981 Oct;245(4):148-68.
DOI
|
45 |
Gazouli M, Yao ZX, Boujrad N, Corton JC, Culty M, Papadopoulos V. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology. 2002 Jul;143(7):2571-83.
DOI
|
46 |
Meroni SB, Riera MF, Pellizzari EH, Cigorraga SB. Regulation of rat sertoli cell function by FSH: possible role of phosphatidylinositol 3-kinase/protein kinase B pathway. J Endocrinol. 2002 Aug;174(2):195-204.
DOI
|
47 |
Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 1997 Jan;62(1):148-58.
DOI
|
48 |
Kim JH, Kim JK, Do BR, Lee CJ, Yoon YD. Evaluation of Bisphenol a Induced Apoptosis in Sertoli Cell-lines. Dev Reprod. 2005;9(2):115-21.
|
49 |
Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664-6.
DOI
|
50 |
Cirino G, Sorrentino R, di Villa Bianca Rd, Popolo A, Palmieri A, Imbimbo C, et al. Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5531-6.
DOI
|
51 |
Kasugai S, Todescan R Jr, Nagata T, Yao KL, Butler WT, Sodek J. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype. J Cell Physiol. 1991 Apr;147(1):111-20.
DOI
|
52 |
Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res. 1993 Dec;8 Suppl 2:S549-55.
DOI
|
53 |
Restak R. The mind. Newyork: Bantam Books; 1988. p. 275-314.
|
54 |
Jones DH, Kong YY, Penninger JM. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii32-9.
DOI
|
55 |
McClung M. Role of RANKL inhibition in osteoporosis. Arthritis Res Ther. 2007; 9(Suppl 1): S3.
DOI
|
56 |
Woessner JF Jr, Gunja-Smith Z. Role of metalloproteinases in human osteoarthritis. J Rheumatol Suppl. 1991 Feb;27:99-101.
|
57 |
Brack AS, Bildsoe H, Hughes SM. Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy. J Cell Sci. 2005 Oct 15;118(Pt 20):4813-21.
DOI
|